Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

Integritas Communications


Access Activity

Overview / Abstract:

Approximately 25% of all individuals infected with HIV are coinfected with HCV.1 Of critical significance, HIV increases the rate of progression of HCV-related hepatic fibrosis, and HCV is associated with a 3-fold increase in HIV antiretroviral therapy-induced liver toxicity.2 Further, these synergistic diseases often occur in adverse socioeconomic conditions that significantly increase the vulnerability and decrease the overall health status of at-risk populations.3 Whereas HIV infection is now effectively manageable, chronic HCV infection is curable. Yet, despite new, highly effective direct-acting antiviral treatment regimens for HCV, their broad-scale use and associated therapeutic successes remain stymied by barriers at the patient, clinician, healthcare system, and jurisdictional levels.4 The BLOCK HIV/HCV initiative will provide community-based infectious disease specialists and other HIV treaters with foundational information and practical resources needed to prepare local stakeholders -- both clinical and nonclinical -- to collaborate in efforts to eliminate HCV within their communities.

1. Centers for Disease Control and Prevention. HIV/AIDS and Viral Hepatitis. Accessed August 30, 2018.

2. Sulkowski MS, Benhamou Y. Therapeutic issues in HIV/HCV-coinfected patients. J Viral Hepat. 2007;14:371-386.

3. Singer M. Introduction to Syndemics: A Critical Systems Approach to Public and Community Health. San Francisco, CA: Jossey-Bass; 2009.

4. National Viral Hepatitis Roundtable (NVHR). Hepatitis C: the State of Medicaid Access. October 23, 2017. Accessed August 30, 2018.


Oct 30, 2019


Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physical Therapy CE, Physician CME, Physician Assistant CME


Webinar / Webcast / Video

Credits / Hours




Presenters / Authors / Faculty

David L. Wyles, MD; Stacey Trooskin, MD, PhD, MPH

Sponsors / Supporters / Grant Providers

Jointly provided by Postgraduate Institute for Medicine and Integritas Communications.

This activity has been supported by an independent educational grant from Gilead Sciences, Inc.

Keywords / Search Terms

Integritas Communications HIV, HCV, CME, CE, credit Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.